Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alterity, Athenex, Aurigene Discovery, Beijing CC-Pharming, Bill & Melinda Gates Foundation, Bridge Biotherapeutics, China Grand, Clover, Curis, Ibio, Oncosec, Porton Pharma Solutions, Q Biomed, Recce.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bluegrass Vascular, Enzo Clinical Labs, Implant Direct, Lucid Diagnostics, Medicrea, Varian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Clinical Trials Mobile Application.

Med-tech firms raising money in public or private financings, including: Co-Diagnostics, Genomic Vision, Myomo, Rewalk Robotics, Speedx, Stilla Technologies, Transenterix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Alr Technologies, Becton Dickinson, Biodesix, Caredx, Catalent, Clarity Pharmaceuticals, Companion Medical, Elypta, Eurofins, Icad, Intuitive Surgical, Limacorporate, Masthercell, Merck, Metactive Medical, Mogene, Natera, Neovasc, Northstar Medical Technologies, Olaris, Oncobeta, Orpheus Medical, P4 Diagnostix, Pfizer, Radiomedix, Resonetics, Royal Philips, Senseonics, Soliton, Strand Diagnostics, Techmah Medical, Tissium, Viracor.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainstorm, Eli Lilly Canada, Fennec, Incyte, Ionis, Janssen, Logicbio, Lyndra, Marker, Novartis, Phasebio, Sirnaomics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Aelian, Aptorum, Biodesix, Briacell, Clene Nanomedicine, CNS, Daewoong, Dianomi, ERS, Genprex, Immune, Kalvista, Kannalife, Luye Pharma, M8 Pharmaceuticals, Merck KGaA, Olaris, Personalis, Pfizer, Synergy, Vistagen, WPD.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Avrobio, Biophytis, Cassava, City of Hope, Crescita, Cyclo, Da Volterra, Dermata, Elicio, Exelixis, Lidds, Moderna, NGM, Pfizer, Seattle Genetics, Sellas, Soligenix, T3D.

Biopharmas raising money in public or private financings, including: Adverum, Agile, Beam, Can-Fite, Collegium, Cortexyme, Diamedica, E-therapeutics, I-Mab, Inotrem, Intelgenx, Moderna, Orphazyme, Phio, Revolution Medicines, Seelos, Spero, Theravance, Xeris.

New hires and promotions in the biopharma industry, including: Aro, Artara, Click, Encoded, Hemostemix, Lyndra, Omeros, Pathios, Selexis.